For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant schizophrenia, and the only one it recognizes as reducing the risk of suicide. This ...
The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine. The agency has eliminated ...
mandating frequent blood tests and database reporting before pharmacies can dispense the drug. Studies also suggest that around 30% of schizophrenia patients could benefit from clozapine ...
Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
Inquirer.net on MSN4d
FDA adds 17 products to list of VAT-free drugsThe Food and Drug Administration (FDA) has added 17 drug products to its list of essential medication exempted from the 12 ...
British drug companies are making a new assault on schizophrenia, with about 16 novel medicines in the pipeline. A number of experimental drugs are designed to alter the chemistry of brain regions ...
AI and 3D printing are being used to help in the treatment of schizophrenia in patients by helping doctors create specialized ...
Abilify Maintena and Abilify Asimtufii are approved to treat schizophrenia and bipolar I disorder‡ in adults. Abilify belongs to a drug class called antipsychotics. Abilify oral tablet is ...
FDA Makes Access to Clozapine Easier for Patients With Schizophrenia By Stephanie Brown HealthDay Reporter FRIDAY, Feb. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results